Compare NICE Ltd (NICE) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs GeneDx Holdings Corp — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: NICE Ltd is far larger — about 3.3× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.
| NICE | WGS | |
|---|---|---|
Market Cap | $5.91B | $1.80B |
Sector | Technology | Technology |
52-Week High | $170.37 | $167.51 |
52-Week Low | $83.15 | $34.51 |
Enterprise Value | $5.69B | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
